본문 바로가기

Survival Outcomes Based on Axillary Surgery in Ductal Carcinoma In Situ : A Nationwide Study From the Korean Breast Cancer Society

문서 유형
연구출판물 · 학술지 논문
등재
KCISCIEScopus
저널 순위
JCR Q3Scopus Q3KCI Q2
저널
JOURNAL OF BREAST CANCER27(1) · pp.1 · 2024
피인용
Web of Science 0Scopus 2KCI 0
FWCI (Scopus)
0.11
JCR IF
JCR 2023 2.2
ISSN
1738-6756

저자

  1. 김봉균제1저자Catholic Univ Korea, Daejeon St Marys Hosp, Coll Med, Dept Surg, Seoul, South Korea
  2. 우주현Ewha Womans Univ, Ewha Womans Univ Coll Med, Dept Surg, Mokdong Hosp, Seoul, South Korea
  3. 이지연Kyungpook Natl Univ, Kyungpook Natl Univ Chilgok Hosp, Sch Med, Dept Surg, Daegu, South Korea
  4. 강은혜Seoul Natl Univ, Coll Med, Dept Surg, Seoul, South Korea
  5. 백수연Ajou Univ, Ajou Univ Med Ctr, Dept Surg, Sch Med, Suwon, South Korea
  6. 이석원Pusan Natl Univ Hosp, Pusan Natl Univ Sch Med, Biomed Res Inst, Dept Surg, Busan, South Korea
  7. 이혁진Saegyaero Hosp, Breast Thyroid Ctr, Busan, South Korea
  8. Lee, JinaCatholic Univ Korea, Daejeon St Marys Hosp, Coll Med, Dept Surg, Seoul, South Korea
  9. 선우영교신저자Catholic Univ Korea, Daejeon St Marys Hosp, Coll Med, Dept Surg, Seoul, South Korea

초록

Purpose In total mastectomy (TM), sentinel lymph node biopsy (SLNB) is recommended but can be omitted for breast-conserving surgery (BCS) in patients with ductal carcinoma in situ (DCIS). However, concerns regarding SLNB-related complications and their impact on quality of life exist. Consequently, further research is required to evaluate the role of axillary surgeries, including SLNB, in the treatment of TM. We aimed to explore the clinicopathological factors and outcomes associated with axillary surgery in patients with a final diagnosis of pure DCIS who underwent BCS or TM. Methods We retrospectively analyzed large-scale data from the Korean Breast Cancer Society registration database, highlighting on patients diagnosed with pure DCIS who underwent surgery and were categorized into two groups: BCS and TM. Patients were further categorized into surgery and non-surgery groups according to their axillary surgery status. The analysis compared clinicopathological factors and outcomes according to axillary surgery status between the BCS and TM groups. Results Among 18,196 patients who underwent surgery for DCIS between 1981 and 2022, 11,872 underwent BCS and 6,324 underwent TM. Both groups leaned towards axillary surgery more frequently for large tumors. In the BCS group, clinical lymph node status was associated with axillary surgery (odds ratio, 11.101; p = 0.003). However, in the TM group, no significant differences in these factors were observed. Survival rates did not vary between groups according to axillary surgery performance. Conclusion The decision to perform axillary surgery in patients with a final diagnosis of pure DCIS does not affect the prognosis, regardless of the breast surgical method. Furthermore, regardless of the breast surgical method, axillary surgery, including SLNB, should be considered for high-risk patients, such as those with large tumors. This may reduce unnecessary axillary surgery and enhance the patients’ quality of life.

키워드

CarcinomaIntraductalNoninfiltratingMastectomySentinel Lymph NodeSurvivalLYMPH-NODE BIOPSYCORE-NEEDLE-BIOPSYSENTINEL NODEAMERICAN-SOCIETYINVASIVE CANCERMASTECTOMYMORBIDITYDCIS

식별자

Scopus EID
2-s2.0-85203793765
WoS UID
001177677200001
KCI
ART003054170